A recursive model depicting a theoretical chain between hypothesized determinants of support for generic drug practices was examined using a maximum likelihood estimation procedure, and applied to samples of 412 physicians and 118 pharmacists. Results suggest that confidence in regulation, potential savings, and impact on drug research represent plausible determinants of physician and pharmacist support of generic drugs.